RedHill Biopharma (RDHL) Inventory Average (2017 - 2025)

RedHill Biopharma (RDHL) has 9 years of Inventory Average data on file, last reported at $3.4 million in Q2 2025.

• On a quarterly basis, Inventory Average fell 16.76% year-over-year to $3.4 million in Q2 2025; TTM through Jun 2025 was $3.4 million, a 16.76% decrease from a year earlier, with the FY2024 full-year figure at $4.0 million, down 47.79% from the prior year.
• Inventory Average for Q2 2025 stood at $3.4 million, down from $3.7 million in the prior quarter.
• Over the last five years, Inventory Average for RDHL reached as high as $14.5 million in Q1 2022 and fell as low as $3.4 million in Q2 2025.
• Historically, Inventory Average has averaged $8.8 million across 5 years, with a median of $8.7 million in 2021.
• Across the five-year window, Inventory Average surged 239.77% in 2021 and sank 60.46% in 2023, its largest moves.
• Year by year, Inventory Average stood at $14.0 million in 2021, then decreased by 15.51% to $11.8 million in 2022, then sank by 60.46% to $4.7 million in 2023, then declined by 20.08% to $3.7 million in 2024, then declined by 8.52% to $3.4 million in 2025.
• Per Business Quant data, the three most recent Inventory Average figures were $3.4 million in Q2 2025, $3.7 million in Q4 2024, and $4.1 million in Q2 2024.